Jeena Sikho Lifecare Limited shareholders approved a final dividend of ₹4.50 per equity share for the financial year ended March 31, 2026, during the company's 9th Annual General Meeting (AGM).

The meeting was held on Monday, September 28, 2026, at the company's venue in Zirakpur, Punjab. In addition to the dividend payout, members adopted both the audited standalone and consolidated financial statements for FY26, along with the reports of the Board of Directors and Statutory Auditors.

Board reappointments and new directorships

The AGM addressed several key governance matters involving the board composition. Mrs. Bhavna Grover was reappointed as Director by rotation and also as Whole-time Director and Key Managerial Personnel through separate resolutions. Mr. Manish Grover was reappointed as Managing Director and Key Managerial Personnel via a special resolution.

Mr. Karan Vir Bindra was reappointed as an Independent Director. The meeting also saw the appointment of new directors to strengthen the board's expertise:

• Mr. Ajay Sharma appointed as Non-Executive Independent Director
• Mrs. Sapna Singh appointed as Non-Executive Woman Independent Director
• Dr. Ish Sharma appointed as Director and Whole-time Director
• Mr. Ankush Kaushal appointed as Director and Whole-time Director

Financial approvals and operational mandates

Members granted specific powers to the Board regarding financial transactions under the Companies Act, 2013. This included approval to grant loans, give guarantees, or provide security to persons covered under Section 185. Additionally, approval was sought for granting loans, giving guarantees or securities, and making investments under Section 186.

Meeting proceedings and compliance

Ms. Priya Goyal, Company Secretary and Compliance Officer, facilitated the electronic voting process supervised by M/s Rawal & Co, Practising Company Secretaries, who served as the Scrutinizer. The remote e-voting facility was active from September 25 to September 27, 2026. The Chairman noted that the Statutory Auditors' Report contained no qualifications or observations requiring member attention, except as otherwise stated. Voting results were scheduled for announcement within two working days of the meeting's conclusion.

Jeena Sikho Lifecare Limited has received in-principle approval from BSE Limited to list up to 6,50,000 equity shares under its Employee Stock Option Scheme 2024. This development completes the regulatory requirement for dual-exchange listing of shares arising from employee stock option exercises.

The approval was granted by BSE vide letter Ref. No. DCS/ESOP/IP/RD/239/2026-27 dated September 22, 2026. The company had previously secured similar in-principle approval from the National Stock Exchange of India Limited on March 14, 2024, when the company was listed solely on NSE.

Share count adjustment due to stock split

The number of equity shares approved for listing reflects a prior corporate action. The original scheme covered 1,30,000 equity shares with a face value of ₹10 each. Following the sub-division of the company's equity shares from a face value of ₹10 to ₹2, the eligible share count adjusted proportionally to 6,50,000 shares.

Regulatory compliance and conditions

The listing is subject to several conditions outlined by BSE. The company must notify the exchange upon allotment of shares and credit to beneficiary accounts or dispatch of share certificates. Additionally, payment of prescribed fees and compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 are mandatory.

The exchange retains the right to withdraw in-principle approval if submitted information is found incomplete, incorrect, or misleading. Trading permission will be issued only after receipt of the final notification under Regulation 10(c) of the SEBI SBEB Regulations.